Np mrd loader

Record Information
Version1.0
Created at2021-01-06 04:57:47 UTC
Updated at2021-07-15 17:31:01 UTC
NP-MRD IDNP0019453
Secondary Accession NumbersNone
Natural Product Identification
Common Name[des-(Leu10-Gly11)]acyclolaxaphycin A
Provided ByNPAtlasNPAtlas Logo
Description(2S,3S)-2-({[(2S)-2-{[(2R,3S)-2-{[(2S,3S)-2-{[(2R)-2-{[(2R)-2-{[(2S)-2-({[(2S,4R)-1-[(2E)-2-{[(2S)-2-{[(3R)-3-amino-1-hydroxyoctylidene]amino}-1,4-dihydroxybutylidene]amino}but-2-enoyl]-4-hydroxypyrrolidin-2-yl](hydroxy)methylidene}amino)-1,4-dihydroxybutylidene]amino}-1-hydroxy-3-phenylpropylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-3-methylpentylidene]amino}-1-hydroxy-3-methylpentylidene]amino}-1-hydroxy-4-methylpentylidene]amino}methyl)-3-methylpentanoic acid belongs to the class of organic compounds known as hybrid peptides. Hybrid peptides are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond. [des-(Leu10-Gly11)]acyclolaxaphycin A is found in Anabaena torulosa. It was first documented in 2012 (PMID: 34383397). Based on a literature review very few articles have been published on (2S,3S)-2-({[(2S)-2-{[(2R,3S)-2-{[(2S,3S)-2-{[(2R)-2-{[(2R)-2-{[(2S)-2-({[(2S,4R)-1-[(2E)-2-{[(2S)-2-{[(3R)-3-amino-1-hydroxyoctylidene]amino}-1,4-dihydroxybutylidene]amino}but-2-enoyl]-4-hydroxypyrrolidin-2-yl](hydroxy)methylidene}amino)-1,4-dihydroxybutylidene]amino}-1-hydroxy-3-phenylpropylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-3-methylpentylidene]amino}-1-hydroxy-3-methylpentylidene]amino}-1-hydroxy-4-methylpentylidene]amino}methyl)-3-methylpentanoic acid (PMID: 30929947) (PMID: 34383398) (PMID: 34383396) (PMID: 34384147) (PMID: 34384146) (PMID: 34384145).
Structure
Thumb
Synonyms
ValueSource
(2S,3S)-2-({[(2S)-2-{[(2R,3S)-2-{[(2S,3S)-2-{[(2R)-2-{[(2R)-2-{[(2S)-2-({[(2S,4R)-1-[(2E)-2-{[(2S)-2-{[(3R)-3-amino-1-hydroxyoctylidene]amino}-1,4-dihydroxybutylidene]amino}but-2-enoyl]-4-hydroxypyrrolidin-2-yl](hydroxy)methylidene}amino)-1,4-dihydroxybutylidene]amino}-1-hydroxy-3-phenylpropylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-3-methylpentylidene]amino}-1-hydroxy-3-methylpentylidene]amino}-1-hydroxy-4-methylpentylidene]amino}methyl)-3-methylpentanoateGenerator
Chemical FormulaC65H109N11O15
Average Mass1284.6490 Da
Monoisotopic Mass1283.81046 Da
IUPAC Name(2S,3S)-2-{[(2S)-2-[(2R,3S)-2-[(2S,3S)-2-[(2R)-2-[(2R)-2-[(2S)-2-{[(2S,4R)-1-[(2E)-2-[(2S)-2-[(3R)-3-aminooctanamido]-4-hydroxybutanamido]but-2-enoyl]-4-hydroxypyrrolidin-2-yl]formamido}-4-hydroxybutanamido]-3-phenylpropanamido]-4-methylpentanamido]-3-methylpentanamido]-3-methylpentanamido]-4-methylpentanamido]methyl}-3-methylpentanoic acid
Traditional Name(2S,3S)-2-{[(2S)-2-[(2R,3S)-2-[(2S,3S)-2-[(2R)-2-[(2R)-2-[(2S)-2-{[(2S,4R)-1-[(2E)-2-[(2S)-2-[(3R)-3-aminooctanamido]-4-hydroxybutanamido]but-2-enoyl]-4-hydroxypyrrolidin-2-yl]formamido}-4-hydroxybutanamido]-3-phenylpropanamido]-4-methylpentanamido]-3-methylpentanamido]-3-methylpentanamido]-4-methylpentanamido]methyl}-3-methylpentanoic acid
CAS Registry NumberNot Available
SMILES
CCCCC[C@@H](N)CC(=O)N[C@@H](CCO)C(=O)N\C(=C\C)C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](CCO)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NC[C@H]([C@@H](C)CC)C(O)=O
InChI Identifier
InChI=1S/C65H109N11O15/c1-13-18-20-25-43(66)33-53(80)68-47(26-28-77)57(82)69-46(17-5)64(89)76-36-44(79)34-52(76)61(86)70-48(27-29-78)58(83)72-51(32-42-23-21-19-22-24-42)59(84)71-50(31-38(8)9)60(85)74-55(41(12)16-4)63(88)75-54(40(11)15-3)62(87)73-49(30-37(6)7)56(81)67-35-45(65(90)91)39(10)14-2/h17,19,21-24,37-41,43-45,47-52,54-55,77-79H,13-16,18,20,25-36,66H2,1-12H3,(H,67,81)(H,68,80)(H,69,82)(H,70,86)(H,71,84)(H,72,83)(H,73,87)(H,74,85)(H,75,88)(H,90,91)/b46-17+/t39-,40-,41-,43+,44+,45+,47-,48-,49-,50+,51+,52-,54+,55-/m0/s1
InChI KeyOMMIGKCKEIRSPW-FUMFDTNBSA-N
Experimental Spectra
Not Available
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 25 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 252 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 50 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 75 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 101 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 151 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 176 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 201 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 226 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
Anabaena torulosaNPAtlas
Chemical Taxonomy
Description Belongs to the class of organic compounds known as hybrid peptides. Hybrid peptides are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassPeptidomimetics
Sub ClassHybrid peptides
Direct ParentHybrid peptides
Alternative Parents
Substituents
  • Hybrid peptide
  • N-acyl-alpha amino acid or derivatives
  • Alpha-amino acid amide
  • Amphetamine or derivatives
  • Alpha-amino acid or derivatives
  • N-acylpyrrolidine
  • Benzenoid
  • Monocyclic benzene moiety
  • Tertiary carboxylic acid amide
  • Pyrrolidine
  • Amino acid
  • Secondary alcohol
  • Carboxamide group
  • Amino acid or derivatives
  • Azacycle
  • Organoheterocyclic compound
  • Organic 1,3-dipolar compound
  • Propargyl-type 1,3-dipolar organic compound
  • Monocarboxylic acid or derivatives
  • Carboxylic acid
  • Carboxylic acid derivative
  • Carboximidic acid derivative
  • Carboximidic acid
  • Organic nitrogen compound
  • Organic oxygen compound
  • Organopnictogen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Primary amine
  • Primary alcohol
  • Organooxygen compound
  • Organonitrogen compound
  • Primary aliphatic amine
  • Carbonyl group
  • Amine
  • Alcohol
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External DescriptorsNot Available
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP-0.03ALOGPS
logP-0.56ChemAxon
logS-4.9ALOGPS
pKa (Strongest Acidic)4.15ChemAxon
pKa (Strongest Basic)9.36ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count16ChemAxon
Hydrogen Donor Count14ChemAxon
Polar Surface Area406.22 ŲChemAxon
Rotatable Bond Count42ChemAxon
Refractivity342.03 m³·mol⁻¹ChemAxon
Polarizability141.44 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
NPAtlas IDNPA025834
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound146682310
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Bornancin L, Alonso E, Alvarino R, Inguimbert N, Bonnard I, Botana LM, Banaigs B: Structure and biological evaluation of new cyclic and acyclic laxaphycin-A type peptides. Bioorg Med Chem. 2019 May 15;27(10):1966-1980. doi: 10.1016/j.bmc.2019.03.046. Epub 2019 Mar 26. [PubMed:30929947 ]
  2. Mitchell PM: The cost-effectiveness of what in health and care?. 2021 Feb. [PubMed:34383398 ]
  3. Authors unspecified: Ozanimod. 2012. [PubMed:34383397 ]
  4. Authors unspecified: Ponesimod. 2012. [PubMed:34383396 ]
  5. Lee J, Cho Y, Choi KH, Hwang I, Oh YL: Metastatic leiomyosarcoma of the thyroid gland: cytologic findings and differential diagnosis. J Pathol Transl Med. 2021 Aug 13. pii: jptm.2021.06.23. doi: 10.4132/jptm.2021.06.23. [PubMed:34384147 ]
  6. Rossouw HM, Nagel SE, Pillay TS: Comparability of 11 different equations for estimating LDL cholesterol on different analysers. Clin Chem Lab Med. 2021 Aug 11. pii: cclm-2021-0747. doi: 10.1515/cclm-2021-0747. [PubMed:34384146 ]
  7. Winkel P, Hilden J, Jakobsen JC, Lindschou J, Jensen GB, Kjoller E, Sajadieh A, Kastrup J, Kolmos HJ, Larsson A, Arnlov J, Bjerre M, Gluud C: A screening method to spot biomarkers that may warn of serious events in a chronic disease - illustrated by cardiological CLARICOR trial data. Clin Chem Lab Med. 2021 Aug 12. pii: cclm-2021-0333. doi: 10.1515/cclm-2021-0333. [PubMed:34384145 ]
  8. Lombardi Y, Hiesse C, Ridel C, Touzot M: From combined heart-kidney to kidney transplantation program: what nephrologists should know about dilated cardiomyopathy. Transpl Int. 2021 Aug;34(8):1573-1575. doi: 10.1111/tri.13948. [PubMed:34384144 ]
  9. Kennedy LJ, Cukier S, Khoury L, Steeves D: 'You drink at home so they can go to work safely': A case study exploring alcohol marketing during the COVID-19 pandemic. Drug Alcohol Rev. 2021 Aug 12. doi: 10.1111/dar.13374. [PubMed:34384143 ]